MedPath

Immunopathologic Profiles and Blood Biomarkers in Patients With IPF

Completed
Conditions
Idiopathic Pulmonary Fibrosis
Registration Number
NCT04187079
Lead Sponsor
University of Aarhus
Brief Summary

Examination of expression of PD-L1, PD-L2, Beta- catenin, B-cell follicles and Tenascin- C in patients with IPF compared with other interstitial lung diseases. Examination of anti HSP 70, p-ANCA, c-ANCA, CD4+/CD28- and CD8+/CD28- cells in patients with IPF compared with other interstitial lung diseases.

Compare the above mentioned findings with changes in pulmonary function tests, 6 minute walking test, exacerbation and mortality over a 2 year follow-up period.

Detailed Description

Examination of expression of PD-L1, PD-L2, Beta- catenin, B-cell follicles and Tenascin- C in cryobiopsies from the lungs inpatients with IPF compared with other interstitial lung diseases. Examination of anti HSP 70, p-ANCA, c-ANCA, CD4+/CD28- and CD8+/CD28- cells in blood samples in patients with IPF compared with other interstitial lung diseases.

Compare the above mentioned findings with changes in pulmonary function tests, 6 minute walking test, exacerbation and mortality over a 2 year follow-up period.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Patients suspected of having an ILD who are having cryobiopsies performed
Read More
Exclusion Criteria
  • BMI > 35
  • DLCO < 35%
  • FVC < 45%
  • Pulmonary hypertension
  • Cardiac or other severe comorbidity that will increase the risk of complications
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PD-L1At diagnosis

Expression of PD-L1 in the epithelial cells in lungs

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Aarhus University Hospital, Department of Respiratory Diseases and Allergy

🇩🇰

Aarhus, Denmark

© Copyright 2025. All Rights Reserved by MedPath